After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Recursion Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Recursion Pharmaceuticals Inc is $4.16B. A total of 71.16 million shares were traded on the day, compared to an average of 19.04M shares.
In the most recent transaction, Gibson Christopher sold 20,000 shares of RXRX for 8.12 per share on Feb 06 ’25. After the transaction, the Chief Executive Officer now owns 1,273,156 company shares. In a previous transaction on Feb 05 ’25, Gibson Christopher sold 20,000 shares at 7.68 per share. RXRX shares that Chief Executive Officer owns now total 1,273,156.
Among the insiders who bought shares, Gibson Christopher acquired of 20,000 shares on Feb 06 ’25 at a per-share price of $8.12. In another insider transaction, Gibson Christopher bought 20,000 shares at $7.68 per share on Feb 05 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, RXRX has a high of $15.74 and a low of $5.60.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RXRX’s latest balance sheet shows that the firm has $516.56M in Cash & Short Term Investments as of fiscal 2021. There were $11.48M in debt and $46.66M in liabilities at the time. Its Book Value Per Share was $1.83, while its Total Shareholder’s Equity was $542.94M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RXRX is Buy with a score of 3.38.
